People with Alzheimer’s disease and other dementias may benefit from creative activities, but hard studies are still lacking.
An antibody against ApoE helps clear plaques and improves cognition in AD model mice.
New twist to fluorescence-based microscopy lets scientists see up-close how Aβ aggregates in living cells.
Conformations of misfolded tau survive injection from one mouse to the next, a property shared by prions.
MetLife rewards research on secretases, toxic Aβ transmission.
By paring back calcium signaling, researchers prevented signs of Alzheimer’s in mice carrying a presenilin mutation. Could the strategy work in humans?
A single dose of a commonly prescribed antidepressant suppresses Aβ production in the human central nervous system.
Mesulam Awarded Potamkin Prize Three’s Company: Florbetaben Approved, Excludes AD Diagnosis PET Tracers Enlighten at Neurology Conference Blood Patterns: Prowling for Alzheimer’s Clues in Plasma Tau imaging of patients with different kinds of dementia and ...
Will an antibody signature make for a new Alzheimer’s diagnostic?
New NIH policies will require researchers to study male and female biology.
Tau and amyloid PET tracers demonstrate potential to sharpen the diagnosis of Alzheimer’s disease and frontotemporal dementias.
Resveratrol consumption failed to correlate with heart disease, inflammation, cancer, or even mortality in a community-based study. Are its benefits overstated?
Known for helping form new memories, new neurons may be just as important for erasing old ones.
Death receptor role in Alzheimer's disease looks less likely than was originally thought following a high-profile paper in 2009.
A gene already well known to counteract aging appears to improve cognition.